Skip to content

Effects of esketamine on postoperative acute pain and cognitive function in patients with gastric colorectal tumors: a randomized controlled study

Effects of esketamine on postoperative acute pain and cognitive function in patients with gastric colorectal tumors: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061276
Enrollment
Unknown
Registered
2022-06-18
Start date
2022-06-06
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute pain and early cognitive dysfunction

Interventions

Experimental group:esketamine
Control group:sufentanil

Sponsors

Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who plan to undergo laparoscopic gastrointestinal surgery and are >= 60 years old, and the type of surgery includes laparoscopic radical resection of gastric cancer, colon cancer, and rectal cancer; American Society of Anesthesiologists (ASA) classification I-III; 2. Agree to postoperative intravenous patient-controlled analgesia; 3. BMI 18-25 kg/m2; 4. Voluntarily participate in the research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of chronic pain; 2. History of opioid or alcohol abuse; 3. The preoperative visit found that the MMSE score of illiteracy < 17 points, primary school < 20 points, and junior high school and above < 24 points; 4. Nervous system diseases; 5. Patients with poorly controlled or untreated hypertension (resting systolic blood pressure/diastolic blood pressure exceeding 180/100 mmHg); 6. Increased intraocular pressure (glaucoma), increased intracranial pressure; 7. Patients with untreated or undertreated hyperthyroidism; 8. Severe cardiopulmonary dysfunction; 9. Severe visual impairment; 10. Lack of cooperation or communication skills; 11. Hypersensitivity to the active ingredients of esketamine or all excipients.

Design outcomes

Primary

MeasureTime frame
Postoperative pain score;patient controlled intravenous analgesia (PCIA) press number;Postoperative recovery quality assessment scale of 15 items;

Secondary

MeasureTime frame
Incidence of delirium 3 days after surgery;self-rating anxiety scale;Self-rating Depression Scale;Athens Insomnia Scale;postoperative complications;

Countries

China

Contacts

Public ContactJiang Peng

Affiliated Hospital of Jiangsu University

doctorjp@163.com+86 13914556527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026